DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

FY21 Advanced Technology Development Award

The list of Fiscal Year 2021 Reconstructive Transplant Research Program Advanced Technology Development Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.

Institution Principal Investigator
Obvia Pharmaceuticals, Ltd.William Fahl

Last updated Sunday, June 5, 2022